Call for Abstracts
Submission Site
Share your knowledge with orthopaedic surgeons from around the world at the 2024 OTA Annual Meeting. The abstract application for podium presentations, breakouts, symposia, and posters is now open. The deadline for all submissions is Feb. 7, 2024.
Submission Categories
|
Podium |
Podium presentations are six minutes in length. There is not a separate submission form for posters. The OTA Program Committee will determine the most effective presentation method, either podium or poster. |
|
Breakout |
One main topic with a moderator and 3 to 4 faculty. Open to questions from the audience. This includes case presentations. Concurrent breakout sessions are held throughout the meeting — 60 min in length. |
|
Main Symposium |
One main topic with a moderator and 3 to 5 faculty. Leave a minimum of 10 minutes for discussion and questions at the end of the session. This is held in the general session room with no conflicting sessions — up to 60 min in length. |
|
Late Breaking |
Abstracts with primary outcome data that are not available at the time of abstract submission. Submitted abstracts will need to include sufficient data for the committee to judge the scientific rigor and magnitude of the research (i.e., demographic data, study interventions, study outcome, follow-up rates, etc.). If accepted, authors will need to provide the Program Committee Chairs an unblinded abstract by August 1, and the full manuscript at the standard September deadline. There will be no exceptions. The Late Breaking category is reserved for high-impact papers, typically multicenter studies with large sample sizes, that are likely to be published in major medical journals and would not be eligible for presentation at the following OTA meeting. |
|
New Technique and Emerging Evidence (Video Format) |
Abstracts submitted to this category address a clinical innovation of interest to the membership, not yet at a level of evidence that supports its inclusion as a typical podium submission. These abstracts may address a clinical problem that requires a more efficient solution, a new technique, or a new implant supported by early clinical data. This category is not designed to serve as an advertisement for a particular commercial product, so please avoid commercial bias. You cannot submit your abstract to both this category and the podium category. You must choose one category. Presentation details/instructions will be provided if accepted. |
View Abstract Guidelines |
FAQs |
OTA Abstract Submission AI Policy |
Financial Conflict of Interest Disclosures: Complete author disclosures will be required and collected within the abstract submission portal for the presenting author, faculty, and the corresponding author / moderator if different from presenting author or faculty at the time of submission. Disclosures must be dated October 17, 2023, or later. Any disclosures made before this date will not be valid. Disclosures are required at the time of submission; the name and email of the author must match exactly to the profile that is in the AAOS database to integrate with the author’s disclosures. Note: Financial disclosures will not be required for co-authors.
For more details on our full disclosure policy, please review here: https://ota.org/disclosures
IMPORTANT DATES
|
February 7, 2024 5:00 PM CST |
Abstract Submission Closes |
|
Late-May 2024 |
Accepted / Declined Notifications Sent |
|
June 2024 |
Annual Meeting Registration Opens |
|
August 1, 2024 |
Late Breaking unblinded abstract due |